Efficacité du reslizumab chez les patients asthmatiques éligibles au traitement par l’omalizumab
Sign Up to like & getrecommendations! Published in 2018 at "Revue Des Maladies Respiratoires"
DOI: 10.1016/j.rmr.2017.10.191
Abstract: Introduction Chez les patients presentant un asthme insuffisamment controle et un taux d’eosinophiles sanguins ≥ 400/μL, reslizumab permet de reduire de facon significative la frequence des exacerbations, d’ameliorer la fonction pulmonaire et le controle de l’asthme… read more here.
Keywords: par; par omalizumab; reslizumab; chez les ... See more keywords
Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects
Sign Up to like & getrecommendations! Published in 2017 at "Therapeutic Advances in Respiratory Disease"
DOI: 10.1177/1753465817717134
Abstract: Eosinophils have long been implicated as playing a central role in the pathophysiology of asthma in many patients, and eosinophilic asthma is now recognized as an important asthma endotype. Eosinophil differentiation, maturation, migration, and survival… read more here.
Keywords: clinical trial; inadequately controlled; treatment; reslizumab ... See more keywords